COVID-19: LMICs need antivirals as well as vaccines.

Bajaj, Simar Singh; Stanford, Fatima Cody

Bajaj, Simar Singh; Stanford, Fatima Cody.

Nature ; 602(7895): 33, 2022 02.

Article in English | MEDLINE | ID: covidwho-1671522

Subject(s)

Antiviral Agents/economics; Antiviral Agents/supply & distribution; COVID-19 Drug Treatment; COVID-19 Vaccines/supply & distribution; COVID-19/prevention & control; Developing Countries; COVID-19/economics; COVID-19/immunology; COVID-19/mortality; Cytidine/analogs & derivatives; Cytidine/economics; Cytidine/supply & distribution; Developed Countries/economics; Developing Countries/economics; Drug Costs; Healthcare Disparities/economics; Healthcare Disparities/statistics & numerical data; Hospitalization/statistics & numerical data; Humans; Hydroxylamines/economics; Hydroxylamines/supply & distribution; Lactams/economics; Lactams/supply & distribution; Leucine/economics; Leucine/supply & distribution; Licensure; Nitriles/economics; Nitriles/supply & distribution; Proline/economics; Proline/supply & distribution

Keywords

Developing world; SARS-CoV-2; Therapeutics; Vaccines

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Developing Countries / COVID-19 Vaccines / COVID-19 / COVID-19 Drug Treatment Type of study: Prognostic study Topics: Vaccines Limits: Humans Language: English Journal: Nature Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google